EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

EUS ‐Guided Gastroenterostomy for Malignant Gastric Outlet Obstruction: Morphological Classification to Prevent Stent Misdeployment

Yu-Ting Kuo iD, Chi-Ying Yang iD, Jiann-Hwa Chen iD, Szu-Chia Liao iD, Cheng-Lin Hsieh, Chia-Hsien Wu, Meng-Ying Lin iD, Chen-Shuan Chung, Kuan-Chih Chen, Mu-Hsien Lee, Hsiang-Yao Shih, Jung-Chun Lin und 4 weitere

Digestive Endoscopy · 2026

DOI: 10.1111/den.70235 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Digestive Endoscopy, 2026. Verfasst von Yu-Ting Kuo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endoscopy, Department of Integrated Diagnostics & Therapeutics, National Taiwan University Hospital, National Taiwan University, Taipei, …. Hauptthemen laut MEDLINE: Gastric Outlet Obstruction, Endosonography, Stents, Gastroenterostomy. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Stent misdeployment is the most critical adverse event (AE) during endoscopic ultrasound‐guided gastroenterostomy (EUS‐GE). This study aimed to identify predictors of misdeployment in EUS‐GE for malignant gastric outlet obstruction (mGOO).

Methods

This multicenter observational study utilized a prospectively maintained registry of consecutive patients undergoing EUS‐GE for mGOO at 13 tertiary centers in Taiwan, with mixed retrospective‐prospective assessment of fluoroscopic morphology (FM) of the gastrointestinal tract near the ligament of Treitz (four types) and EUS morphology (EM) of the target bowel (three types). The primary outcome was the misdeployment. Multivariable analysis identified predictors of misdeployment and survival.

Results

Between July 2020 and June 2025, 165 patients were enrolled. Technical and clinical success rates were 98.2% and 95.2%, respectively. Overall AE rate and misdeployment rates were 7.3% and 4.8%, respectively. Same‐session endoscopic salvage succeeded in 87.5% of misdeployment cases. EM type C (cross‐sectional bowel view) carried the highest misdeployment risk (33%) and was the sole independent predictor (adjusted odds ratio 16.9; p = 0.001). FM provided essential complementary risk stratification; FM type II was more common among misdeployment cases (25.0% vs. 3.8%; p = 0.030). Implementation of a stepwise strategy in 2023—prioritizing EM type A/B, avoiding type C, and minimizing stomach–bowel distance—resulted in zero misdeployment. Independent predictors of poor survival included pancreatic cancer, malnutrition, poor performance status, ascites, metastasis, and misdeployment.

Conclusion

Stent misdeployment is a significant complication adversely impacting survival. Utilizing integrated EM and FM risk stratification within a stepwise strategy can minimize misdeployment and optimize clinical outcomes. Trial Registration ClinicalTrials.gov: NCT07230665

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastric Outlet ObstructionEndosonographyStentsGastroenterostomyUltrasonography, InterventionalHumansFemaleMaleRetrospective StudiesAgedMiddle Aged

Autor:innen und Institutionen

  • Division of Endoscopy, Department of Integrated Diagnostics & Therapeutics, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
  • Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Department of Internal Medicine, Center for Digestive Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Tzu Chi Hospital & School of Medicine, Tzu Chi University, Hualien, Taiwan.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.

ORCID-Profile: Yu-Ting Kuo, Chi-Ying Yang, Jiann-Hwa Chen, Szu-Chia Liao, Meng-Ying Lin

Zitieren

APA

Kuo, Y. T., Yang, C. Y., Chen, J. H., Liao, S. C., Hsieh, C. L., Wu, C. H., Lin, M. Y., Chung, C. S., Chen, K. C., Lee, M. H., Shih, H. Y., Lin, J. C., Sun, C. K., Tsai, M. C., Wang, H. P., & Taiwan EUS‐GE Study Group (TEGESG) (2026). EUS ‐Guided Gastroenterostomy for Malignant Gastric Outlet Obstruction: Morphological Classification to Prevent Stent Misdeployment. Digestive Endoscopy. https://doi.org/10.1111/den.70235

Vancouver

Kuo YT, Yang CY, Chen JH, Liao SC, Hsieh CL, Wu CH, et al. EUS ‐Guided Gastroenterostomy for Malignant Gastric Outlet Obstruction: Morphological Classification to Prevent Stent Misdeployment. Digestive Endoscopy. 2026. doi:10.1111/den.70235

BibTeX
@article{Kuo2026,
  author = {Kuo, Yu-Ting and Yang, Chi-Ying and Chen, Jiann-Hwa and Liao, Szu-Chia and Hsieh, Cheng-Lin and Wu, Chia-Hsien and Lin, Meng-Ying and Chung, Chen-Shuan and Chen, Kuan-Chih and Lee, Mu-Hsien and Shih, Hsiang-Yao and Lin, Jung-Chun and Sun, Cheuk-Kay and Tsai, Ming-Chang and Wang, Hsiu-Po and Taiwan EUS‐GE Study Group (TEGESG), Taiwan EUS‐GE Study Group (TEGESG)},
  title = {EUS ‐Guided Gastroenterostomy for Malignant Gastric Outlet Obstruction: Morphological Classification to Prevent Stent Misdeployment},
  journal = {Digestive Endoscopy},
  year = {2026},
  doi = {10.1111/den.70235}
}
Kostenlos starten →